
| Opening Page | Managing Costs | P4P Trends | Outlook 2006 | HSA Regulations | Future Care | ||||||
Co-sponsored by MCOL and CPRi Communications: Employers and health plans wrestling with coverage guidelines, cost-sharing options and utilization controls for specialty pharmaceuticals will learn proven strategies that integrate specialty benefit management (SBM), disease management (DM) and PBM programs to achieve savings while enhancing clinical outcomes. This Mini Web Summit runs from November 17 through November 21 , 2003.
This mini-summit includes live two audioconference / webcast sessions, with four presentations available for review 24/7 via the web summit. The faculty has agreed to answer e-mail questions during the mini summit, and includes :
Attendees will also receive an electronic Key Contacts Directory, both in searchable on-line format, and a downloadable version in adobe acrobat format.
Audioconferences
/ Webcasts
Two live audioconference/ webcast
sessions are available. Each session is
scheduled for 45 minutes in length, with time allotted for questions and
answers. Please note attendees bear their own costs for any long distance phone
charges.
Presentations:
| Summit Overview: Solving the Specialty Pharmacy Cost Dilemma | |
![]() |
Michael Ellis is senior vice president of specialty pharmacy for AdvancePCS, the nation's leading independent health improvement company. He led the company's entry into the specialty pharmacy business. His primary responsibility is to formulate the specialty pharmacy service offering to the AdvancePCS payer clients and operationalize the logistics of the program. |
| Michael Ellis Senior Vice President, Specialty Pharmacy AdvancePCS |
|
| Specialty Benefit Management: A New Solution To Your Rising Drug Costs | |
![]() |
Alan T. Wright, M.D. is senior vice
president and chief science officer for AdvancePCS,
the nation’s leading independent health improvement company. He
is responsible for overseeing disease management research and product
development, outcomes research programs and identifying appropriate health
care alliances and opportunities for partnerships or acquisitions that are
aligned with the corporate mission for specialty
products and emerging technologies. |
|
Alan Wright, M.D. Senior Vice President, Chief Science Officer AdvancePCS Also available as a live audioconference / webcast session |
|
| Integrating Disease Management to Impact Chronic Care | |
|
|
Steven
K. Schelhammer founded Accordant, an AdvancePCS company, in 1995 because
he recognized an opportunity to reform certain aspects of the health-care
delivery system and improve care for individuals living with complex,
chronic diseases. As president, he guides the strategic direction of the
company and remains very active in new business development initiatives.
Mr. Schelhammer has more than 10 years’ experience with chronic disease
management, and was recipient of the Carolinas’ prestigious Year 2000
Ernst & Young Entrepreneur of the Year award. |
|
Steve
Schelhammer |
|
| Biotechnology and Specialty Benefit Management | |
|
|
Thomas
Gallucci is Merrill's senior Healthcare Distribution/Technology, Lab & Pharmacy Benefit Management Analyst. Mr. Gallucci has worked in healthcare equity research since 1995, covering a variety of services sectors during that time. He previously worked with Mr. A.J. Rice, covering the services/facilities segments of the health care industry. Mr. Gallucci was one of eight Institutional Investor "Home Run Hitters" in 2001. He joined Merrill Lynch in February, 1999, and prior to that worked with Mr. Rice at both Bear, Stearns and CS First Boston. Mr. Gallucci began his career at Ernst & Young, and holds a B.S. in Accounting from Lehigh University. |
|
Thomas
Gallucci Senior Healthcare Distribution/Technology, Lab & Pharmacy Benefit Management Analyst Merrill Lynch |
|
|
|
Eric J.
Ende, M.D., Merrill Lynch Senior Analyst covers the Biotechnology industry. Prior to joining Merrill Lynch in 2002, Ende was a Managing Director at Banc of America Securities since 2000 where he also followed the Biotechnology sector. He worked for Lehman Brothers as a biotech research analyst from 1997 to 2000. In 2002, Dr. Ende received Second Team honors in the Institutional Investor "All-America" Research Survey, improving on his Third Team honors in 2001 and Best Up and Comer ranking by the magazine in 2000. He was also voted #2 in the 2003 Greenwich Poll and #3 in 2002 in addition to being voted the #1 stock-picker both years.
|
|
Eric J.
Ende, M.D. Senior Analyst Merrill Lynch |
|
Key
Contacts Directory:
Attendees
receive the adobe acrobat version, plus a special searchable version on the web
Free
Thirty Day MCOL Paid Membership:
Registrants (not already MCOL paid members) will receive a free 30 day MCOL
bronze paid membership (a $15.00 value) good for November 2003, which provides
access to MCOL’s paid member web site with extensive health management and
managed care resources, and MCOL’s coveted paid member e-mail delivery
services.
About
CPRi
CPRi
Communications is a leading provider of marketing communications services to the
healthcare and life sciences industries. Through focused strategic planning and
creative, tactical implementation, CPRi
has successfully positioned numerous vendors and service providers in all
major professional and consumer segments of the healthcare industry. CPRi's
full-service capabilities include public relations, brand identity consulting
and development, Web site design, advertising and media planning, market
research and analysis, and outsourced business development programs. Our
programs and services are always implemented to generate increased visibility
and optimal return-on-investment. For
more information, visit www.cpronline.com
or contact Andy Weissberg: 201.641.1911 x25 or e-mail aweissberg@cpronline.com.
This event co-sponsored by MCOL and CPRi Communications.